TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
YARW

Yarrow Bioscience Inc

Healthcare · Biotechnology

25.50$ -2.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Yarrow Bioscience Inc (YARW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.6 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement YARW
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.7 4.6 11 0.4 21 0.9 0.5 0.4 0.5 0.6
– – – – 0.4 1.4 – – – – 0.0
– 0.7 4.6 11 0.1 20 0.9 0.5 0.4 0.5 0.5
2.9 11 29 53 54 44 20 18 16 31 19
1.7 3.8 5.2 12 22 – – 16 13 13 11
4.6 15 34 65 76 -233 40 35 30 44 30
-4.6 -14 -30 -55 -76 253 -39 -34 -29 -44 -30
– – – – 0.9 4.4 5.6 – – – –
-4.6 -14 -29 -51 -74 -256 -44 -34 -28 -40 -27
– – 0.0 – -3.2 -0.3 0.4 0.0 – 0.0 0.0
-4.6 -14 -29 -51 -70 -256 -73 -23 -28 -40 -26
-4.6 -14 -30 -55 -94 -251 -38 -34 -28 -40 -27

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?